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Abstract
Background—Atherosclerotic plaques demonstrate extensive accumulation of oxidative DNA 
damage, predominantly as 8-oxoguanine (8oxoG) lesions. 8oxoG is repaired by base excision
repair (BER) enzymes; however, the mechanisms regulating 8oxoG accumulation in vascular 
smooth muscle cells (VSMCs) and its effects on their function and in atherosclerosis are 
unknown.
Methods—We studied levels of 8oxoG and its regulatory enzymes in human atherosclerosis, the
mechanisms regulating 8oxoG repair and the BER enzyme 8oxoG DNA glycosylase I (OGG1) 
in VSMCs in vitro, and the effects of reducing 8oxoG in VSMCs in atherosclerosis in ApoE-/-
mice.
Results—Human plaque VSMCs showed defective nuclear 8oxoG repair, associated with 
reduced acetylation of OGG1. OGG1 was a key regulatory enzyme of 8oxoG repair in VSMCs,
and its acetylation was crucial to its repair function, through regulation of protein stability and 
expression. p300 and SIRT1 were identified as the OGG1 acetyltransferase and deacetylase 
regulators respectively, and both proteins interacted with OGG1 and regulated OGG1 acetylation
at endogenous levels. However, p300 levels were decreased in human plaque VSMCs and in 
response to oxidative stress, suggesting that ROS-induced regulation of OGG1 acetylation could 
be due to ROS-induced decrease in p300 expression.  We generated mice that express VSMC-
restricted OGG1 or an acetylation defective version (SM22α-OGG1 and SM22α-OGG1K-R mice) 
and crossed them with ApoE-/- mice. We also studied ApoE-/- mice deficient in OGG1 (OGG1-/-).
OGG1-/- mice showed increased 8oxoG in vivo and increased atherosclerosis, whereas mice 
expressing VSMC-specific OGG1, but not the acetylation mutant OGG1K-R, showed markedly 
reduced intracellular 8oxoG and reduced atherosclerosis. VSMC OGG1 reduced telomere 8oxoG 
accumulation, DNA strand breaks, cell death and senescence after oxidant stress, and activation
of pro-inflammatory pathways.
Conclusions—We identify defective 8oxoG BER in human atherosclerotic plaque VSMCs, 
OGG1 as a major 8oxoG repair enzyme in VSMCs, and p300/SIRT1 as major regulators of
OGG1 through acetylation/deacetylation. Reducing oxidative damage by rescuing OGG1 activity 
reduces plaque development, indicating the detrimental effects of 8oxoG on VSMC function.
Key Words: Atherosclerosis; DNA damage; Oxidative damage; DNA glycosylases; Vascular 
Disease
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Clinical Perspective
What is new?
x We demonstrate that human atherosclerosis exhibits increased oxidative DNA damage 
and defective repair of that damage in vascular smooth muscle cells (VSMCs).
x Defective base-excision repair (BER) is due to reduced expression, acetylation and 
activity of the enzyme OGG1 in atherosclerosis. 
x OGG1 is a major BER enzyme in VSMCs, whose activity and protein stability are 
regulated by acetylation through the p300acetyltransferase and sirtuin 1 deacetylase 
enzymes.
x Correcting the BER defect in VSMCs alone markedly reduces plaque formation,
indicating that endogenous levels of oxidative DNA damage in VSMCs promote plaque 
development.
What are the clinical implications?
x Oxidative DNA damage accumulates slowly in atherosclerosis and disappears only very 
slowly when hyperlipidemia is corrected.
x Oxidative DNA damage causes inflammation, cell death and cell senescence, all of which 
promote atherogenesis.
x OGG1 protects VSMCs against oxidative DNA damage, identifying BER as a possible 
therapeutic target in atherosclerosis.
x Protection against oxidative DNA damage or increased DNA repair are beneficial over 
and above the standard clinical approach of reducing risk factors for coronary artery 
disease that promote damage, including hypercholesterolemia, diabetes mellitus, and 
smoking.
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Non-standard Abbreviations and Acronyms 
Ac-OGG1 acetyl-OGG1
ApoE apolipoprotein E
BER base excision repair
BSA bovine serum albumin
CCL2 C-C Motif chemokine ligand 2
ChIP chromatin immunoprecipitation
DDR DNA damage response
GFP green fluorescent protein
IL interleukin
Lys lysine
MCP1 monocyte chemotactic protein 1
NLRP NACHT, LRR and PYD domains-containing protein
OGG1 8-oxoguanine DNA Glycosylase
PCR polymerase chain reaction
PLA proximity ligation assay
ROS reactive oxygen species
SIRT1 sirtuin 1
αSMA α-smooth muscle actin
TNFα tumor necrosis factor α
TUNEL terminal UTP nick end-labeling
VSMCs vascular smooth muscle cells
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Introduction
DNA bases are susceptible to oxidation mediated by reactive oxygen species (ROS). The low
redox potential of guanine makes it especially vulnerable and leads to a plethora of oxidized 
guanine products1. 8-oxoguanine (8oxoG) is the most abundant DNA lesion formed upon 
oxidative exposure, and the presence of 8oxoG is often used as a cellular biomarker to indicate 
extent of oxidative stress. 8oxoG is a highly mutagenic miscoding lesion that can lead to G:C to 
T:A transversion mutations and is widely found in human disease and aging2. However, it is 
often unclear whether 8oxoG accumulation is just a marker of oxidative stress or has a 
pathogenetic role in disease.
Base excision repair (BER) is the primary mechanism for repairing 8oxoG. BER involves 
the concerted effort of several repair proteins that recognize and excise oxidized bases, replacing 
the damaged moiety with a normal nucleotide and restoring DNA integrity3. BER is a critical 
process for genomic maintenance, as highlighted by the severe phenotypes of mice deficient in 
BER function, including premature aging and metabolic defects4. However, with the exception 
of specific BER gene mutations, evidence of defective BER and whether it contributes to human 
disease is limited.
Advanced atherosclerotic plaques are characterised by 8oxoG accumulation in vascular 
smooth muscle cells (VSMCs), macrophages and endothelial cells5,6. 8oxoG also accumulates in 
plaques in fat-fed animals, but normalizes only slowly on a normal diet5. The persistence of 
DNA damage can reflect both ongoing damage-inducing stimuli, for example through ROS, 
and/or defects in DNA repair. A number of inherited defects that impair DNA repair are 
associated with human atherosclerosis or can promote atherosclerosis in animal models 
(reviewed in 7). In contrast, whether the far lower endogenous levels of 8oxoG found in 
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atherosclerosis affect plaque development is not known. A recent study has showed that
knockout of the DNA glycosylase 8-Oxoguanine DNA Glycosylase (OGG1) in macrophages
promotes atherosclerosis, and OGG1 transcript expression was reduced in human plaques
compared to normal vessels8; however, whether the observed decreased OGG1 expression 
translates into DNA repair defects is unknown.
We show that human atherosclerotic plaque VSMCs have defective 8oxoG BER,
associated with decreased expression and acetylation of OGG1. We establish OGG1 as a major 
8oxoG repair enzyme in VSMCs, and that OGG1 activity in VSMCs is controlled by 
Lys338/Lys341 acetylation. We identify p300 and sirtuin 1 (SIRT1) as major acetyltransferase
and deacetylase enzymes directly targeting OGG1, and thus regulating 8oxoG BER and 8oxoG
content in VSMCs. p300 expression is reduced in plaque VSMCs and by oxidative stress, and 
reduced formation of the p300-OGG1 complex compromises OGG1 activity and protein stability.
Importantly, inhibiting endogenous oxidative damage by rescuing VSMC OGG1 markedly
reduces atherosclerosis in vivo, an effect that requires OGG1 acetylation. Our findings indicate 
that human atherosclerosis is characterized by defective 8oxoG BER, and endogenous levels of 
oxidative DNA damage in VSMCs promote atherosclerosis.
Methods
The data that support the findings of this study are available within the article, data supplement
and from the corresponding author upon reasonable request.
Human atherosclerotic plaque and normal vessels
Human tissue was obtained under informed consent using protocols approved by the Cambridge 
or Huntingdon Research Ethical Committee. Atherosclerotic plaques and normal aorta were 
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obtained from separate patients undergoing carotid endarterectomy or aortic valve replacement 
respectively. 
Experimental animals
All in vivo experiments followed United Kingdom Home Office licensing and were approved by 
the local animal ethical committee. Transgenic mice were generated as described in the online-
only Data Supplement. The global OGG-/- and SM22α-SIRT1ex4/ex4 conditional transgenic 
mouse models were generated as described previously9,10. OGG1-/- mouse embryos were a gift 
from Christi Walter (University of Texas Health Science Center, Texas, USA). 
Atherosclerosis protocols
Male and female littermate Control ApoE-/-, SM22α-OGG1/ApoE-/-, and SM22α-OGG1K-
R/ApoE-/- mice were fed High Fat ‘Western’ Diet (829-100, Special Diet Services, HFD-21% 
total fat, 0.2% cholesterol, 0% sodium cholate) from 8-22 weeks.
Histological Analysis and Oil Red O staining of descending aorta
Atherosclerosis extent and composition was analyzed as described previously10 and in the
online-only Data Supplement.
Cell culture
Human, rat and mouse VSMCs were cultured as described previously11 and in the online-only 
Data Supplement.
Transfections and virus infections
Transfections and retrovirus infections were performed as described previously10 and in the
online-only Data Supplement.
CRISPR-mediated gene silencing
Gene silencing experiments were performed as described in the online-only Data Supplement.
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Real-time polymerase chain reaction
Oligonucleotide sequences used are listed in Table 1 in the online-only Data Supplement.
Oligonucleotide incision assay
8oxoG BER activity in nuclear lysates was determined as described previously12 and in the
online-only Data Supplement.
8oxoG ELISA
8oxoG levels were assessed using an ELISA assay (Abcam) as described in the online-only 
Data Supplement.
Intracellular ROS measurement
Intracellular ROS was measured as described previously13 and in the online-only Data 
Supplement.
Annexin V/PI flow cytometry
Cell death was determined using an Apoptosis Detection kit (BD BioSciences) as described in
the online-only Data Supplement.
Comet assay
Comet assay was performed using mouse VSMCs as described previously11 and in the online-
only Data Supplement.
Immunofluorescence
Immunofluorescence analysis was performed as described previously14 and in the online-only 
Data Supplement.
Immunoprecipitation and Western blotting
Immunoprecipitation assays and Western blotting were performed as described previously11 and 
in the online-only Data Supplement.
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ChIP-qPCR
Chromatin immunoprecipitation (ChIP) was performed as described in the online-only Data 
Supplement.
Statistical analysis
Sample sizes were selected on the basis of previous experiments that identified significant 
differences in plaque development in mice. No randomization was applied as all mice used were 
genetically defined, inbred mice. Blinding was employed and no animals were excluded from 
analysis. Data shown are mean±SEM. Normality of distribution was determined using 
D’Agostino-Pearson omnibus normality tests. Statistical significance was determined by one-
way analysis of variance (ANOVA) followed by Bonferroni post-test when more than two 
groups were compared and a two tailed Student’s t-test to compare two groups of data using 
Prism 6.0 (Graph Pad). Differences were considered statistically significant with a P value<0.05.
Results
Human atherosclerotic plaque VSMCs show reduced BER activity
Previous studies have shown that advanced human atherosclerotic plaques display increased 
8oxoG lesions in cells expressing VSMC or macrophage markers compared with normal 
arteries15. Studies also show that plaques have increased ROS content compared with normal 
vessels16,17, so that increased 8oxoG may be due to increased oxidative stress within the plaque, 
or defective BER, or both. We therefore examined 8oxoG repair in VSMCs cultured from human 
carotid plaques or normal aorta from patients matched for age and sex, with cultures matched for 
passage number. Cells were fractionated into nuclear and cytoplasmic compartments to assay 
nuclear or mitochondrial BER respectively (Supplemental Figure I), and 8oxoG repair activity 
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examined using a fluorescently-labeled 8oxoG-containing molecular beacon that can be incised 
and assayed in real time. Plaque VSMCs showed marked reduction in nuclear 8oxoG repair 
activity compared with aortic VSMCs, but cytoplasmic 8oxoG repair activity was similar in both
cell types (Figure 1a).
Although 8oxoG repair is mediated by a number of enzymes, knockout studies suggest 
that OGG1 is a major, non-redundant enzyme responsible for repairing 8oxoG from the bulk of
the genome in many tissues18 and that activation of alternate pathways cannot compensate for 
OGG1 deficiency. OGG1 mRNA was increased in human plaque VSMCs 1.5-fold on qPCR 
(Figure 1b), but plaque VSMCs showed reduced total OGG1 protein expression compared to
aortic VSMCs, and a marked reduction in Acetyl-OGG1 (Ac-OGG1) expression (Figure 1c). To 
determine whether protein expression in vitro reflects expression in VSMCs in vivo, we 
examined 8oxoG, Ac-OGG1 and OGG1 expression in human coronary plaques from American 
Heart Association grade IV lesions compared with normal undiseased aorta, co-labeled with
αSMA to identify VSMCs. 8oxoG lesions were increased in human plaque VSMCs (Figure 1d).
Consistent with the in vitro data, human plaque VSMCs showed reduced percentage of VSMCs 
expressing total OGG1 and a markedly reduced percentage of VSMCs expressing Ac-OGG1 vs.
aortic VSMCs (Figure 1d), suggesting that increased oxidative damage in plaque VSMCs may 
be due to decreased expression and acetylation of OGG1.
OGG1 is a major BER enzyme in VSMCs
To determine whether OGG1 is an important regulator of 8oxoG BER in VSMCs, we knocked 
down OGG1 in vitro using CRISPR/Cas9 to delete exon 1 or 7 in rat VSMCs. OGG1 expression 
was efficiently and stably reduced in OGG1Exon1KO or OGG1Exon7KO cells (Figure 2a), with no 
compensatory effect on expression of other BER enzymes such as NEIL1 and NTH 
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(Supplemental Figure IIa). Oxidative DNA damage was stimulated by treatment with tert-butyl 
hydroperoxide (t-BHP) for 1h, which induces oxidative stress and 8oxoG in VSMCs15, cells
were left to recover for 0-24h, and 8oxoG BER activity examined. t-BHP transiently inhibited 
BER activity in control cells which then normalized by 24h; OGG1 knockdown reduced both
basal and t-BHP-induced 8oxoG BER activity, such that OGG1 was responsible for >95% of 
8oxoG BER activity (Figure 2b). Consistent with t-BHP-induced inhibition of BER, t-BHP also 
increased intracellular 8oxoG content in VSMCs (Figure 2c), with recovery albeit incomplete by 
24h. OGG1Exon1KO and OGG1Exon7KO cells showed higher basal and t-BHP-induced intracellular 
8oxoG, which was completely unchanged to 24h (Figure 2c), confirming that OGG1 is a major 
BER enzyme repairing 8oxoG in VSMCs.
Repair of 8oxoG requires OGG1 acetylation
To determine whether 8oxoG repair activity requires OGG1 acetylation in VSMCs, we stably
expressed wild type human OGG1, OGG1K-R or the empty vector in rat VSMCs by retrovirus-
mediated gene transfer. OGG1K-R is an acetylation site mutant in which Lys-338 and Lys-341
(which are active in 8oxoG repair19) are replaced by arginines. Exogenous human OGG1 was 
expressed at comparable levels in OGG1 and OGG1K-R cells (Figure 2d), localized to the 
nucleus (Supplemental Figure IIb), and did not suppress endogenous rat OGG1 expression
(Figure 2d). However, Ac-OGG1 expression was increased in OGG1 but not OGG1K-R VSMCs 
(Figure 2d). OGG1, but not OGG1K-R cells showed significantly increased 8oxoG BER after t-
BHP compared with control cells (Ctrl) expressing the empty vector alone (Figure 2e). Ctrl,
OGG1, and OGG1K-R VSMCs showed similar intracellular baseline 8oxoG, and similar 8oxoG
levels after 1h t-BHP treatment; however, OGG1 but not OGG1K-R VSMCs displayed more rapid 
removal of 8oxoG (Figure 2f). To exclude the possibility that expression of OGG1 altered ROS
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generation by t-BHP, we examined ROS levels at baseline and after t-BHP in the 3 cell lines; 
ROS levels were identical in Ctrl, OGG1 and OGG1K-R VSMCs at both baseline and after t-BHP
(Supplemental Figure IIc), indicating that OGG1 acetylation regulates efficiency of 8oxoG
removal after oxidative stress without affecting ROS.
OGG1 acetylation and stability is regulated by p300
Although the acetyltransferase p300 can acetylate OGG1 in cancer cells19, the major 
acetyltransferase and deacetylase enzymes of OGG1 in VSMCs are not known, or their 
expression in atherosclerosis. We examined p300 expression in cultured normal aortic and 
plaque VSMCs, and whether VSMC OGG1 and 8oxoG repair activity were regulated by p300.
Both p300 mRNA (Supplemental Figure IIIa) and protein expression (Figure 3a) were 
reduced in plaque compared with aortic VSMCs, and the % of VSMCs expressing p300 was also 
reduced in plaque VSMCs in vivo (Supplemental Figure IIIb). To examine whether oxidative 
stress could be the underlying cause of reduced p300 levels in plaque VSMCs, we treated control 
VSMCs with 1h t-BHP and examined OGG1, Ac-OGG1, and p300 protein expression up to 24h 
recovery. t-BHP reduced both Ac-OGG1 and p300 expression in parallel, which did not 
normalize by 24h (Figure 3b, Supplemental Figure IIIc), suggesting that ROS-induced 
reduction of OGG1 acetylation is due to ROS-induced decrease in p300 expression. The reduced 
OGG1 acetylation and p300 expression even at 24 h after t-BHP treatment (Figure 3b) may 
explain the incomplete 8oxoG repair seen in control cells (Figure 2c).
To examine whether p300 interacts with OGG1 at endogenous levels of expression in 
VSMCs, human VSMC lysates were immunoprecipated with an anti-p300 antibody and probed 
for OGG1. p300 associated with OGG1 at endogenous levels of expression, and p300 complex 
formation with OGG1 was reduced by t-BHP (Figure 3c). Proximity ligation assay (PLA)
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confirmed the p300/OGG1 interaction in human VSMCs and localized it primarily to the nucleus 
(Figure 3d, negative controls shown in Supplemental Figure IIId). To determine if p300 
regulates OGG1 acetylation and BER, we examined Ac-OGG1 expression and BER activity in
OGG1 or OGG1K-R cells treated with 1h t-BHP and 24h recovery ± CTPB, a specific activator of 
p300 HAT activity20,21. CTPB induced hyperacetylation of histone 4 as expected22 (Figure 3e).
Importantly, CTPB induced acetylation of endogenous rat and exogenous human OGG1 in 
OGG1 cells, but human OGG1 remained unchanged in OGG1K-R cells (Figure 3e). CTPB also 
increased 8oxoG repair activity in OGG1 cells but not in OGG1K-R cells (Figure 3f, 
Supplemental Figure IVa), in line with the effects on OGG1 acetylation. Furthermore, the p300 
inhibitor C64623 inhibited BER in VSMCs (Supplemental Figure IVb).
Our findings that OGG1 mRNA is increased in human plaque VSMCs, but expression of 
OGG1 and acetylated OGG1 protein are reduced, suggests that both expression and activity of 
OGG1 are controlled by post-translational mechanisms. We therefore examined the stability of 
OGG1 protein in cells treated with cycloheximide to prevent de novo protein synthesis. 
Cycloheximide reduced expression of endogenous rat OGG1 in Ctrl, OGG1 and OGG1K-R
VSMCs to a similar extent; in contrast, the reduction in human OGG1 was slower in OGG1 cells
compared to OGG1K-R VSMCs, suggesting that acetylation of OGG1 promotes its stability 
(Supplemental Figure IVc). To determine whether p300 regulates OGG1 stability, we repeated 
this experiment ± the p300 activator CTPB. CTPB enhanced the stability of OGG1 in OGG1 
cells, but not in OGG1K-R cells (Figure 3g, Supplemental Figure IVd). We also tested whether 
p300 regulates OGG1 stability through its degradation. OGG1 stability was reduced in the 
presence of the p300 inhibitor C646, but OGG1 expression was restored after additional 
administration of the proteasomal inhibitor MG132 (Figure 3h, Supplemental Figure IVe),
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indicating that p300 regulates OGG1 expression and proteasomal-mediated degradation through 
its acetylation.
SIRT1 is an OGG1 deacetylase in VSMCs
The deacetylase responsible for inhibiting OGG1 activity in VSMCs is unknown, as although 
OGG1 interacts with class I histone deacetylases, previous studies showed that activity was not 
affected by the SIRT1 inhibitor nicotinamide19. We therefore examined whether VSMC OGG1 
and BER activity were regulated by SIRT1.
To determine whether OGG1 interacts with and is deacetylated by SIRT1, we generated 
VSMCs that stably express wild type human SIRT1 or the deacetylase-deficient mutant 
SIRT1H365Y by retrovirus-mediated gene transfer10. VSMCs expressing the empty vector (Ctrl),
SIRT1 or SIRT1H-Y were treated with t-BHP and SIRT1, Ac-OGG1 and OGG1 protein
expression examined. SIRT1 but not SIRT1H-Y reduced Ac-OGG1 and total OGG1 expression
(Figure 4a), suggesting that OGG1 is a SIRT1 deacetylation substrate. Indeed, SIRT1 co-
immunoprecipitated with OGG1 both at endogenous levels and when overexpressed (Figure 4b),
and PLA in human VSMCs confirmed this protein interaction at endogenous levels (Figure 4c, 
Supplemental Figure Va). Consistent with SIRT1 reducing OGG1 acetylation, SIRT1 but not 
SIRT1H-Y reduced 8oxoG repair activity (Figure 4d, Supplemental Figure Vb), and increased 
intracellular 8oxoG content (Figure 4e). SIRT1 but not SIRT1H-Y also reduced OGG1 stability 
(Figure 4f), consistent with SIRT1 deacetylation of OGG1. Since SIRT1 is both regulated by 
redox-mediated mechanisms and can inhibit ROS generation (reviewed in 24,25), the differences 
in 8oxoG levels after t-BHP could be due to different levels of ROS induced in each cell type;
however, ROS levels in Ctrl, SIRT1 or SIRT1H-Y cells after t-BHP were similar (Supplemental 
Figure Vc). Finally, we examined expression of OGG1 and Ac-OGG1 in aortas from ApoE-/-
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mice that express a truncated inactive SIRT1 (SIRT1∆ex4/∆ex4) from the SMC-specific SM22α
(transgelin, Tagln) promoter10. SIRT1 expression was detectable in <1% of VSMCs in SM22-
SIRT1∆ex4/∆ex4 ApoE-/- mice, confirming the efficacy of the recombination. OGG1 expression was 
seen at similar levels in SM22-SIRT1∆ex4/∆ex4 ApoE-/- and control mice; in contrast Ac-OGG1 
expression was increased in SM22-SIRT1∆ex4/∆ex4 ApoE-/- mice consistent with SIRT1 
deacetylation of OGG1 (Figure 4g). Together these data indicate that SIRT1 binds to and 
regulates OGG1deacetylation and stability, and thus regulates oxidative damage in VSMCs.
VSMC OGG1 reduces oxidative damage and atherosclerosis in vivo
Whole body or bone marrow cell-restricted knockout of OGG1 results in increased 
atherosclerosis in low density lipoprotein receptor-null mice8. However, OGG1 knockout results 
in massive 8oxoG accumulation, and the effects of endogenous levels of 8oxoG found in 
atherosclerosis and VSMC OGG1 are not known. We therefore generated mice expressing myc-
tagged human OGG1 or OGG1K-R from the minimal SM22α promoter (SM22α-OGG1 or 
SM22α-OGG1K-R mice). This promoter is expressed in VSMCs in large arteries only26, and has 
an additional deletion of the CARG motif to prevent promoter down-regulation during VSMC 
phenotypic change in atherosclerosis27. SM22α-OGG1 and SM22α-OGG1K-R mice were 
compared against control mice and OGG1-/- mice9. Mouse OGG1 mRNA expression was 
markedly reduced in all tissues in OGG1-/- mice, but not affected by co-expression of human 
OGG1 in SM22α-OGG1 or SM22α-OGG1K-R mice (Supplemental Figure VIa). Previous 
studies have also shown that the full-length SM22α promoter is also expressed in myeloid 
cells28; in contrast, the minimal SM22α promoter-driven human OGG1 transgene was only 
expressed in aortas of SM22α-OGG1 mice, but not peripheral blood, bone marrow cells or
spleen (Supplemental Figure VIb).
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OGG1 protein expression was markedly reduced in VSMCs cultured from OGG1-/- mice, 
but increased in SM22α-OGG1 and SM22α-OGG1K-R mice to similar levels (Figure 5a). Ac-
OGG1 expression was increased in SM22α-OGG1 mouse VSMCs but not SM22α-OGG1K-R
VSMCs, while myc tag expression was observed only in transgenic lines (Figure 5a). ELISA of
cultured VSMCs from these mice showed increased 8oxoG in OGG1-/- mice, and reduced 8oxoG 
in SM22α-OGG1 but not SM22 α-OGG1K-R mice (Figure 5b). 8oxoG repair activity was 
increased in SM22α-OGG1 VSMCs, reduced in OGG1-/- VSMCs, but unchanged in SM22α-
OGG1K-R VSMCs compared with control cells (Figure 5c, Supplemental Figure Vic). Thus,
OGG1-/- mice allow examination of the effect of supraphysiological levels of 8oxoG in all tissues 
on atherosclerosis; SM22α-OGG1 mice allow determination of the effect of rescuing OGG1 
activity and suppressing endogenous levels of 8oxoG in VSMCs only, and SM22α-OGG1K-R
mice provide the acetylation-mutant control for SM22α-OGG1 mice.
Control wild type, OGG1-/-, SM22α-OGG1 and SM22α-OGG1K-R mice were crossed 
onto an ApoE-/- background, weaned at 6 weeks and male and female littermates were fat fed 
from 8-22 weeks of age. Weight gain (Supplemental Figure VIIa), serum lipids (Supplemental 
Figure VIIb), systolic, diastolic and mean arterial pressures, and heart rates were similar across 
all groups pre- and post- fat feeding (Supplemental Figure VIIc). Atherosclerosis was increased 
in the descending aorta and aortic root in OGG1-/- ApoE−/− mice compared with controls (Figure
6a, 6b), but markedly decreased in both vascular beds in SM22α-OGG1 ApoE−/− mice; this 
protective effect was lost in SM22α-OGG1K-R ApoE−/− mice. Both necrotic core and fibrous cap 
areas were reduced in SM22α-OGG1 ApoE−/− mice (Figure 6c) compared to controls, with no 
overall change in relative proportions of the necrotic core and fibrous cap to the plaque or to 
each other (Supplemental Figure VIIIa). Analyses of male and female mice were grouped 
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together (Supplemental Figure VIIIb) as we found no significant differences between sexes for 
any parameters measured except for body weight (not shown). Aortic plaques in SM22α-OGG1 
mice had reduced 8oxoG levels compared to SM22α-OGG1K-R and control mice, correlating 
with reduced plaque area, and significantly fewer TUNEL-positive apoptotic cells compared to 
SM22α-OGG1K-R mice (Supplemental Figure VIIIc).
Oxidative DNA damage accumulates at telomeres, and induces strand breaks, cell 
senescence, apoptosis, and drives inflammation
Although VSMC OGG1 protected against atherosclerosis, the underlying mechanisms, which 
may be multiple, are unclear. For example, defects in BER can cause DNA strand breaks
resulting in cell death. Indeed, OGG1-/- VSMCs showed increased DNA strand breaks after t-
BHP treatment with a reduced rate of repair; DNA damage was lower in SM22α- OGG1 but not 
SM22α-OGG1K-R VSMCs vs. control cells (Figure 7a). 8oxoG accumulation at telomeres can 
result in cell senescence and subsequent inflammation. Indeed ChIP-qPCR showed that OGG1-/-
VSMCs had increased 8oxoG accumulation at telomeres, and this was reduced in SM22α-OGG1,
but not SM22α-OGG1K-R cells (Figure 7b). The % of cells expressing senescence-associated β-
galactosidase after t-BHP was increased in OGG1-/- VSMCs, but reduced in SM22α-OGG1, but 
not SM22α- OGG1K-R cells (Figure 7c, Supplemental Figure IX). Finally, t-BHP-induced cell 
death was increased in OGG1-/-, and reduced in SM22α-OGG1 but not SM22α- OGG1K-R cells 
(Figure 7d), indicating that OGG1 overexpression protects VSMCs against apoptosis, but this 
depends upon OGG1 acetylation.
Oxidized DNA can also activate the inflammasome, resulting in release of pro-
inflammatory cytokines such as IL-1β8. Using qPCR, we profiled aortic arch tissue from ApoE-/-
mice after high fat diet feeding for levels of inflammatory cytokines and inflammasome 
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components. SM22α-OGG1 ApoE-/- aortic tissue contained significantly decreased levels of 
transcripts for cytokines IL1β, IL6, CCL2/MCP1 and TNFα and inflammasome components 
NLRP1 and NLRP3 Figure 7e, indicative of a shift toward a more anti-inflammatory phenotype,
with an opposite profile seen in OGG1-/- ApoE-/- mice. Serum levels of IL1β, IL6, CCL2/MCP1
and TNFα were also decreased in SM22α-OGG1 ApoE-/- mice after high fat diet feeding 
compared to controls (Supplemental Figure Xa). To identify the source of these cytokines, we 
cultured VSMCs from these mice and determined cytokine secretion following t-BHP treatment 
for 24h. t-BHP did not increase levels of IL1β, IL6, MCP1 and TNFα in conditioned media of 
SM22α-OGG1 ApoE-/- cells, compared to SM22α-OGG1K-R ApoE-/- and control ApoE-/- cells
(Supplemental Figure Xb). The anti-inflammatory profile in vivo of OGG1 mice and in culture 
of OGG1 VSMCs suggests that 8oxoG in VSMCs may exert a direct pro-inflammatory effect on 
the vessel wall.
Discussion
Advanced human atherosclerotic plaques demonstrate extensive 8oxoG accumulation in multiple 
cell types5,6, and polymorphisms in some BER enzymes are associated with myocardial 
infarction29, suggesting that impaired BER might promote plaque development or instability. 
Indeed, OGG1 knockout in hematopoietic cells promotes atherogenesis and enhanced 
inflammasome activation in macrophages8. However, VSMCs are long–lived cells30, and the
effects of oxidative DNA damage in VSMCs in atherosclerosis are not known. In particular,
chronic oxidative stress can increase 8oxoG levels >250-fold without apparent severe 
consequences31, and OGG1-/- mice are born and develop normally with a normal lifespan, despite 
a 7-fold increase 8oxoG in nuclear DNA and a >20-fold increase in mitochondrial DNA9,32-34.
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More controversially, some studies suggest that 8oxoG may actually protect against 
inflammation-induced DNA damage35-37.
Our study reports a number of novel findings. In particular, we demonstrate (a) evidence 
of defective 8oxoG BER in human plaque VSMCs, not just increased damage or reduced 
expression of BER enzymes, (b) reducing physiological 8oxoG levels reduces atherosclerosis, in
addition to the detrimental effects of artificially-elevated 8oxoG, (c) the importance of OGG1 
acetylation to its function in vivo, (d) that SIRT1 regulates OGG1 acetylation in vivo, and (e) that
p300 regulates OGG1 stability, not just activity. Specifically, we find that OGG1 is a major BER 
enzyme in VSMCs, whose activity and protein stability are regulated by acetylation. Nuclear 
8oxoG repair is defective in human atherosclerotic plaque VSMCs, associated with reduced 
acetylation of OGG1, which results in proteasomal-mediated OGG1 degradation and reduced 
activity. Our findings identify that atherosclerosis is a disease characterised by defective BER in
VSMCs, and that endogenous levels of oxidative DNA damage in VSMCs promote plaque 
development. 
Human atherosclerotic plaques show a variety of DNA damage, including single and 
double strand breaks, telomere shortening, oxidative DNA damage and mutations (reviewed in 7).
Plaque VSMCs also show differences in expression of multiple DNA damage repair (DDR) 
proteins, indicative of activation of a DDR response11. Some human DNA damage syndromes 
are associated with premature atherosclerosis, and previous studies in mice have shown that 
knockout of some DNA repair enzymes can promote atherosclerosis or vascular dysfunction8,38,
suggesting that DNA damage may promote atherosclerosis. Indeed, a recent study showed
downregulation of OGG1 transcripts in human plaque tissue compared with normal vessels8. In 
contrast, we find that OGG1 mRNA is increased in human plaque VSMCs, while total OGG1 
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protein expression is decreased compared to aortic VSMCs. This difference is likely due to the 
analyses being performed in whole plaque tissue8, which contains a heterogeneous mixture of 
cells, versus VSMC cultures in this study. However, this is the first study to demonstrate that 
human atherosclerosis exhibits a DNA repair defect in VSMCs, that defect is due to reduced 
expression, acetylation and activity of a specific DNA repair protein, and that correction of that 
defect in VSMCs alone can markedly reduce plaque formation.
Vascular smooth muscle cells in the normal vessel wall are characterized by low rates of 
cell division, cell death, and cell senescence, and maintain a contractile phenotype that expresses 
low levels of inflammatory cytokines (reviewed in 39). In contrast, VSMCs in atherosclerotic 
plaques or cultured from plaques show higher rates of cell death and cell senescence, 
accompanied by secretion of a variety of pro-inflammatory cytokines, some of which may be due 
to cell senescence40,41. Cell death and cell senescence promote both plaque development and 
plaque progression in atherosclerosis42,43. Oxidative DNA damage may affect multiple processes 
within VSMCs, and we show that VSMCs lacking OGG1 show increased cell death, cell 
senescence and expression of inflammasome components, all of which are pro-atherogenic, and 
all of which can be inhibited by overexpression of OGG1 after oxidative stress. Loss of OGG1 
also increases oxidized mitochondrial DNA, inflammasome activation, and apoptosis in 
macrophages8. However, the profound reduction in plaque formation in SM22α-OGG1 
compared with control mice demonstrates that endogenous levels of 8oxoG found in VSMCs in 
atherosclerosis promote plaque development, and emphasize the importance of oxidative DNA 
damage-mediated activation of cell death and senescence in VSMCs, and of VSMC-driven 
inflammation in atherogenesis.
 by guest on June 18, 2018
http://circ.ahajournals.org/
D
ow
nloaded from
 
10.1161/CIRCULATIONAHA.117.033249
21
Our data also demonstrate the complex effects of oxidative stress in DNA repair. 
Acetylation regulates multiple protein properties, such as stability, localization, function and 
protein-protein interactions44. OGG1-mediated BER activity is regulated by acetylation of
lysines K338/K341 (19 and shown here). Previous work in mouse embryonic fibroblasts showed 
decreased OGG1K-R repair activity in vitro19, but not the total loss of activity we observe in 
VSMCs, implying that acetylation may be a more important modification for OGG1 activity in 
VSMCs compared with other cell types. We also show that p300 and SIRT1 are major 
acetyltransferase and deacetylase enzymes respectively for OGG1 acetylation, but the 
mechanisms of their effects, and the effects of oxidative stress may differ between cells. For 
example, although p300 can interact with OGG1 in some cell types19, oxidative stress enhances
histone acetyltransferase activity of p300 in lung cells with no change in expression; in contrast,
p300 protein expression was downregulated following oxidative stress in VSMCs. Consistent
with previous studies19 ROS also transiently decreased OGG1 activity directly, which may be 
due to the reduced state of the redox-sensitive residues that determine its glycosylase activity45,46.
Our findings emphasise the detrimental effect of chronic oxidative stress in atherosclerosis
through a positive feedback loop to generate further oxidative DNA damage. ROS induce
oxidative DNA damage but also impair 8oxoG BER by downregulating OGG1 directly, and 
indirectly through inhibiting p300 expression and thus OGG1 acetylation and protein stability.
This finding may explain the observation that oxidative DNA damage persists much longer in 
atherosclerosis than other forms of DNA damage, even when the pro-atherogenic stimulus is 
removed5.
Although the regulation of OGG1 activity by acetylation is known19, the identity of the 
OGG1 deacetylase has not been proven. SIRT1 is a NAD+-dependent lysine deacetylase with 
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roles including cell ageing, genomic stability and cell apoptosis47, but it has been excluded 
previously as the SIRT1 inhibitor nicotinamide did not increase OGG1 acetylation in HCT116 
cells19. However, an association of SIRT1 and OGG1 was not tested directly, and we have found 
that SIRT1 substrates are tissue-specific10. We identify that SIRT1 is a major enzyme regulating 
OGG1 activity, and its activity depends upon its ability to deacetylate OGG1. Thus, SIRT1 but
not SIRT1HY reduces OGG1 acetylation, reduces 8oxoG repair and promotes persistence of 
oxidative DNA damage. SIRT1 deletion in vivo also increases Ac-OGG1, indicating that SIRT1 
can regulate OGG1 activity at endogenous levels. However, SIRT1 is downregulated in human 
atherosclerotic plaques, and in plaque and senescent VSMCs compared with normal VSMCs in 
culture10, suggesting that SIRT1 regulation of OGG1 may be particularly relevant in normal 
arteries as a way of deactivating OGG1 when oxidative DNA repair is complete, but less
important in atherosclerosis where the reduced p300 expression results in reduced acetylated 
OGG1. However, SIRT1 also activates other components of the BER pathway including the 
enzymes Thymine DNA Glycosylase, Apurinic/apyrimidinic endonuclease 1 and Poly(ADP-
Ribose) Polymerase 148,49, which may partly explain the profound effect of VSMC SIRT1 
knockout in atherosclerosis10.
Our findings are consistent with the following model (Figure 8). OGG1 is preferentially 
acetylated by p300 in acute oxidative stress conditions that require 8oxoG repair activity, leading 
to efficient 8oxoG BER. Ac-OGG1 is deacetylated by SIRT1 when 8oxoG BER is complete.
However, chronic oxidative stress in atherosclerosis results in downregulation of p300 and p300-
mediated acetylation of OGG1, which in turn reduces OGG1 protein stability and thus 
expression, and overall 8oxoG repair activity. ROS may also reduce OGG1 activity directly via 
its effects on redox-sensitive residues and glycosylase activity45,46. 8oxoG accumulation in 
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VSMCs results in DNA strand breaks, cell senescence, cell death, inflammasome activation and 
increased secretion of pro-inflammatory cytokines, all of which promote atherogenesis. Rescue 
of VSMC OGG1 prevents 8oxoG accumulation and these consequences, protecting against 
atherosclerosis.
In summary, we have identified that 8oxoG repair is reduced in VSMCs in human 
atherosclerosis, due to chronic oxidative stress-induced reduction in expression, stability, 
acetylation and activity of OGG1. SIRT1 is also a major regulator of OGG1 acetylation, 
expression and activity. OGG1 protects VSMCs against oxidative DNA damage, cell senescence 
and apoptosis, and reduces atherosclerosis formation, identifying BER as a possible therapeutic 
target in atherosclerosis.
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Figure Legends
Figure 1. Human plaque VSMCs show defective nuclear base excision repair activity and 
reduced acetyl-OGG1 expression
(a) BER assay measuring incision of a fluorescently-labelled 8oxoG.C oligonucleotide in nuclear 
and cytoplasmic fractions of cultured plaque and normal aortic VSMCs. Representative gel (left 
panel) and quantification (right panel) are shown. Incision product denoted by an arrow (n=4).
(b) qPCR analysis of OGG1 expression in cultured plaque and normal aortic VSMCs (n=4). (c)
Western blot of OGG1 and acetylated OGG1 (Ac-OGG1) in plaque and normal aortic VSMCs
(n=4). (d) Immunohistochemistry for 8oxoG, Ac-OGG1, or OGG1 (brown) in sections of human
plaques and normal aorta (n=10). Sections are also co-stained for αSMA (blue). Insets show high 
power views of outlined areas. Negative controls using isotype-matched antibodies and 
quantification are shown below. Scale bars, 25μm. All graphical data are mean ± SEM, *P< 0.05, 
**P< 0.01, Student's t-test.
Figure 2. OGG1 is the major BER enzyme for 8oxoG and its activity is regulated by 
acetylation
(a) OGG1 protein expression in control or OGG1 exon1 or exon7 CRISPR knockout rat VSMC 
lines (n=4). (b) BER assay analysis and (c) 8oxoG intracellular levels measured by ELISA in
control (Ctrl), OGG1Exon1KO or OGG1Exon7KO rat VSMCs at untreated baseline (-) or after t-BHP 
treatment for 1h (t=0) and after t-BHP removal (4, 8, 24h recovery) (n=5). (d) Western blot of
OGG1, Ac-OGG1, or myc tag in rat VSMCs expressing the empty vector (Ctrl), human OGG1 
(OGG1) or acetylation mutant OGG1 (OGG1K-R). Immunoblotting for OGG1 shows a lower 
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band for endogenous rat OGG1 and a higher band for exogenous human OGG1 (n=4). (e) BER 
assay analysis and (f) 8oxoG intracellular levels measured by ELISA in Ctrl, OGG1 or OGG1K-R
cells at untreated baseline (-) or after t-BHP treatment for 1h (t=0) and after t-BHP removal (4, 8, 
24h recovery) (n=4). All graphical data are mean ± SEM, *P< 0.05, **P< 0.01, ***P< 0.001, 
one-way ANOVA (Bonferroni post hoc).
Figure 3. p300 is downregulated in plaque VSMCs and regulates OGG1 acetylation and 
BER
(a) Western blot of p300 expression in cultured human plaque or normal aortic VSMCs (n=4).
(b) Western blot of OGG1, Ac-OGG1 and p300 levels in human VSMCs after 1h t-BHP
treatment and 0-24h recovery (n=4). (c) Immunoprecipitation of human VSMC lysates with an 
anti-p300 antibody analysed by immunoblotting (IB) with anti-OGG1 and anti-p300 antibodies
(n=3). (d) Proximity ligation assay of OGG1-p300 interaction using rabbit anti-OGG1 and 
mouse anti-p300 antibodies (n=3). Scale bar, 20μm. (e) Western blot for Ac-OGG1 and Ac-
Histone 4(H4) in VSMCs expressing OGG1 or OGG1K-R ± CTPB treatment (10μM) (n=3). (f)
Quantification of BER assay in OGG1 or OGG1K-R VSMCs either untreated (-), after 1h t-BHP
(0) or 6h recovery ± CTPB (n=3). Representative gel is shown in Supplemental Figure IVa. (g)
Western blot of OGG1 expression after cycloheximide (CHX) treatment (0-4h) in OGG1 or 
OGG1K-R VSMCs ± p300 activator CTPB (n=3). (h) Western blot of OGG1 expression after 
cycloheximide (CHX) treatment (0-4h) in control cells ± CTPB ± proteasomal degradation 
inhibitor MG132 (10 μM)(n=3). Scale bars, 25μm. All graphical data are mean ± SEM, *P< 0.05, 
Student's t-test.
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Figure 4. SIRT1 binds OGG1 and regulates deacetylation of OGG1 in vitro and in vivo
(a) Western blot of total SIRT1, Ac-OGG1 and OGG1 expression in rat VSMCs expressing the 
empty vector (Ctrl), human SIRT1 (SIRT1) or deacetylase defective mutant SIRTH364Y cells after 
1h t-BHP treatment and after 0-6h recovery (n=3). Immunoblotting for SIRT1 shows a lower 
band for endogenous rat SIRT1 and a higher band for exogenous human SIRT1. (b)
Immunoprecipitation of human VSMC lysates with an anti-SIRT1 antibody analysed by 
immunoblotting (IB) with anti-SIRT1 and anti-OGG1 antibodies (n=3). (c) Proximity ligation 
assay of OGG1-SIRT1 interaction using rabbit anti-OGG1 and mouse anti-SIRT1 antibodies
(n=3). (d) Quantification of BER assay in Ctrl, SIRT1 or SIRT1H-Y VSMCs either untreated (-),
after 1h t-BHP (0) or 0-24h recovery (n=3). Representative gel is shown in Figure Vb in the 
online-only Data Supplement. (e) 8oxoG intracellular levels measured by ELISA in control,
SIRT1 or SIRT1H-Y VSMCs after 1h t-BHP treatment and after 0-24h recovery (n=3). (f) Western 
blot of OGG1 expression after CHX (0-4h) treatment of control, SIRT1 or SIRT1H-Y VSMCs
(n=3). (g) Immunohistochemistry for SIRT1, OGG1 or Ac-OGG1 (brown) in aortas from control 
ApoE-/- or SIRT1-/-/ApoE-/- mice (n=10). Tissue sections were also co-stained for αSMA (blue).
Negative control sections with isotype-matched antibodies are shown below. Scale bar, 25μm.
All graphical data are mean ± SEM, *P< 0.05, ***P< 0.001, one-way ANOVA (Bonferroni post 
hoc).
Figure. 5 OGG1 regulates 8oxoG expression in VSMCs in vivo and BER
(a) Western blot of OGG1, Ac-OGG1 and myc tag in VSMCs cultured from wild type (control),
OGG1-/-, SM22α-OGG1, or SM22α-OGG1K-R mouse aortas (n=4). (b) 8oxoG intracellular levels 
measured by ELISA in Control, OGG1-/-, SM22α-OGG1, or SM22α-OGG1K-R VSMCs (n=4).
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(c) BER assay quantification in Control, OGG1-/-, SM22α-OGG1, or SM22α-OGG1K-R VSMCs
treated with t-BHP for 1h and recovered for up to 24h (n=4). All graphical data are mean ± SEM, 
*P< 0.05, one-way ANOVA (Bonferroni post hoc).
Figure 6. Effects of OGG1 on plaque development and morphology in vivo
(a) Representative images and quantification of en face preparations of descending aortas from
Control ApoE-/- (n=12), OGG1-/- ApoE-/- (n=14), SM22α-OGG1 ApoE-/- (n=12) and SM22α-
OGG1K-R ApoE-/- (n=13) mice stained with Oil Red O. Scale bar, 2mm. (b) Hematoxylin-eosin 
(H&E) and Masson’s trichome immunohistochemistry of Control ApoE-/- (n=12), OGG1-/- ApoE-
/- (n=14), SM22α-OGG1 ApoE-/- (n=12) and SM22α-OGG1K-R ApoE-/- (n=13) mouse aortic roots 
at 22 weeks after fat feeding from 8 to 22 weeks. Quantification of % plaque size, plaque area,
core area and cap area (μm2). Scale bar, 200 μm. All graphical data are mean ± SEM, **P< 0.01, 
***P < 0.001, one-way ANOVA (Bonferroni post hoc).
Figure 7. OGG1 regulates DNA strand breaks, cell senescence, apoptosis, and 
inflammasome pathways
(a) Comet assay with quantification for cultured VSMCs from wild type control, OGG1-/-,
SM22α-OGG1, or SM22α-OGG1K-R mice treated with t-BHP for 1h and recovered for 6h (n=3).
Scale bar, 100μm. (b) Chromatin immunoprecipitation-qPCR using primers to a telomeric 
region on 8oxoG-bound chromatin from control, OGG1-/-, SM22α-OGG1, or SM22α-OGG1K-R
mouse VSMCs (n=3). Data are shown as fold-change over IgG. (c) % VSMCs expressing 
senescence-associated beta galactosidase activity (SaβG) from wild type control, OGG1-/-,
SM22α-OGG1, or SM22α-OGG1K-R mice (n=3). (d) Apoptosis assayed by Annexin V and 
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propidium iodide staining of mouse cells ± t-BHP treatment by flow cytometry (n=3). (e)
Relative expression of transcripts for inflammatory cytokines and inflammasome-associated 
components in aortic arch tissue from Control ApoE-/-, OGG1-/- ApoE-/-, SM22α-OGG1 ApoE-/-
and SM22α-OGG1K-R ApoE-/- mice after fat feeding (n=4). All graphical data are mean ± SEM, 
*P<0.05, **P<0.01, ***P<0.001, one-way ANOVA (Bonferroni post hoc).
Figure 8. Model of OGG1 regulation in VSMCs in atherosclerosis
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SUPPLEMENTAL MATERIAL 
 
SUPPLEMENTAL METHODS 
 
Generation of transgenic mice 
To produce transgenic mouse targeting constructs, myc-tagged hOGG1 or OGG1K-R cDNA 
was subcloned between the minimal SM22α promoter and a polyA sequence in pBluescript. 
The SM22α-OGG1 and SM22α-OGG1K-R transgenes were digested with BssHII and the 
transgene-containing fragment purified from an agarose gel. Transgenic mice were 
generated by pro-nuclear injection of SM22α-OGG1 and SM22α-OGG1K-R fragments into 
C57Bl6 embryos, and positive progeny used to generate individual lines.  
 
Genotyping 
Ear notches from transgenic mice were incubated with Chelex/Proteinase K for 2h at 56˚C. 
Following heat inactivation at 95˚C, 2 µl DNA was used in the subsequent PCR reaction. 
ApoE-/- genotyping was conducted according to Jackson Labs protocols and cycling 
conditions: 94˚C for 10 min, followed by 40 cycles of 94˚C for 45s, 63˚C for 45s and 72˚C for 
90s. OGG1 genotyping was performed using the following cycling conditions: 95˚C for 5 min, 
followed by 40 cycles of 95˚C for 1 min, 62˚C for 2 min and 72˚C for 90s. SM22α-OGG1 
transgene expression was analysed using primers that amplify a 550 bp region of OGG1 
fused to the C-terminal myc tag using the following cycling conditions: 95˚C for 5 min, 
followed by 40 cycles of 94˚C for 1 min, 57˚C for 1 min and 72˚C for 1 min. PCR products 
were analysed on a 2% agarose gel containing ethidium bromide. Oligonucleotide 
sequences used for genotyping are listed in Supplementary Table S1. 
 
For heterozygosity genotyping, digested ear notches were diluted 1:10 and underwent 
standard 2 step qPCR (Rotor-gene Q). Briefly, 3µl DNA was used in a qPCR reaction 
containing 2x PCR mastermix (Life Technologies), 20x human OGG1 or mouse GAPDH 
Taqman primer-probes (Life Technologies) and H2O. Samples were analysed for OGG1 
gene expression and normalized to GAPDH expression. Heterozygosity was defined by 
analysing the OGG1:GAPDH ratio whereby no expression corresponded to null animals; 
heterozygous animals had gene expression at 50% of the value of homozygous-positive 
animals. 
 
Blood pressure analysis and cytokine detection 
Blood pressure was determined by tail cuff measurements. V-PLEX Mouse Proinflammatory 
Panel 1 and U-PLEX Chemokine Combo immunoassays (Meso Scale Discovery, Maryland, 
USA) were used to determine cytokine concentrations in conditioned media from cell lines or 
mouse serum. Samples were analyzed according to the manufacturer’s recommendations. 
 
Oil Red O staining of descending aorta	
Oil Red O (0.2 g, Sigma) was dissolved in 100 ml of isopropanol and filtered through 
Whatman No. 1 filter paper (stock solution). The working stain was prepared by diluting the 
stock solution with distilled water (6:4). Adventitial tissue was carefully removed from the 
descending aorta, the artery opened along the longitudinal axis, rinsed in distilled water, 
rinsed in 60 % isopropanol for 30 sec, stained with Oil Red O working stain for 15 min, 
rinsed again in isopropanol and returned to distilled water. The vessel was laid flat on a 
glass slide, mounted in water, covered with a coverslip and imaged en face using an 
Olympus BX51 microscope equipped with an Olympus Lumenera Infinity 3 digital camera 
and analyzed using ImageJ software. The percentage of the luminal surface area stained by 
Oil Red O was determined. 
 
Histological Analysis 
Atherosclerosis extent and composition was analyzed as described previously9. Briefly, 
sections from the aortic root were stained with Haematoxylin and Eosin (H&E), Masson’s, 
	 2	
8oxoG and TUNEL. Plaque extent and composition was measured using ImageJ analysis 
software with an observer blind to experimental group. SMA content of fibrous caps was 
defined using Masson’s Trichrome to identify the fibrous cap region. Fibrous caps were 
defined as the area rich in VSMCs and proteoglycan overlying the cholesterol-rich, matrix-
poor, acellular regions of the necrotic cores. Very small plaques (<90,000µm2) were not 
included in the above analysis since it was impossible to demarcate a fibrous cap.  
 
Cell culture 
Human, rat and mouse VSMCs were cultured in Dulbecco’s modified Eagle’s medium 
(DMEM, Sigma) supplemented with 100 U/ml penicillin, 100 μg/ml streptomycin, 2 mM L-
glutamine, and 10 % FCS.  
 
Human VSMCs were cultured from explants. The endothelial layer was removed using a 
scalpel and tissue cut into 2-3mm² pieces, placed into 6-well plates containing 1ml media 
and grown for 1-2 weeks to allow cells to emerge. Human VSMCs were studied at passages 
2–5; VSMC cultures from individual patients were not pooled. Rat and mouse aortic VSMCs 
were prepared by removing surrounding tissues and enzymatic dispersion using Type I 
collagenase (1 mg/ml, Sigma) and elastase (0.5 mg/ml, Worthington Biochemical) in serum-
free medium for 1h at 37 °C. 
 
Cells were treated with tert-butyl hydrogen peroxide (t-BHP, Sigma), C646 (Sigma), CTPB 
(Sigma), cycloheximide (Sigma) or MG132 (Sigma) as indicated in figure legends. 
 
Transfections and virus infections 
Retrovirus infection was used to produce stable expression of wild type OGG1 or the 
acetylation mutant OGG1K-R in rat aortic VSMCs. hOGG1 was subcloned from pCMV-myc-
Nuc-hOGG1 (Addgene) and site-directed mutagenesis performed using the QuikChange 
Lightning Multi Site-Directed Mutagenesis Kit (Stratagene) following the manufacturer’s 
instructions.  
 
pBabe-puro vectors encoding human OGG1 or OGG1K-R were used to transfect PhoenixTM 
packaging cells (Orbigen) using SuperFect (Qiagen). Virus-producing cells were selected 
with hygromycin B (300 μg/ml; Calbiochem). VSMCs were infected with the virus suspension 
in the presence of 8 μg/ml Polybrene (hexadimethrine bromide, Sigma), and selected with 5 
μg/ml of puromycin (Sigma).  
 
CRISPR-mediated gene silencing 
For gene silencing experiments, rat aortic VSMCs were transfected with a U6-gRNA/CMV-
Cas9-GFP CRISPR plasmid targeting OGG1 (Sigma). To generate rat OGG1-/- VSMCs, 
cells were trypsinized 3 days after transfection and resuspended in PBS with 0.1% BSA and 
2 mM EDTA. Single GFP-positive cells were sorted by FACS into 96-well plates, and clonal 
cell populations expanded. OGG1 protein expression of each clone was examined by 
immunoblotting, and clones with efficient OGG1 knockout used for further studies. Genomic 
DNA was extracted from 1 × 106 cells, and locus-specific cleavage was analyzed using the 
GeneArt Genomic Cleavage Detection Kit (Life Technologies).  
 
Real-time polymerase chain reaction 
RNA extraction from mouse tissues and primary VSMCs was performed using the RNeasy 
kit (Qiagen). First strand cDNA synthesis was performed using Superscript III Reverse 
Transcriptase (Invitrogen). Quantitative real-time PCR was performed using Rotor-Gene 
SYBR Green PCR Kit (Qiagen) on a Rotor-Gene 6000 QPCR thermocycler (Corbett 
Research). Oligonucleotide sequences used are listed in Supplementary Table S1. 
 
Oligonucleotide incision assay 
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8oxoG BER activity in nuclear lysates was determined using a 40-mer oligonucleotide 
containing an 8oxoG at position 19 and labelled at the 3’ end with indodicarbocyanine (5’-
AGAGAAGAAGAAGAA(G*)AGATGGGTTATTCGAA-CTAGC-Cy5Sp-3’). This 
oligonucleotide was hybridized to its complementary sequence containing a cytosine 
opposite the 8oxoG lesion (G*). Nuclear extracts were added to a 10μL standard incision 
reaction mixture containing 200 fmoles of the 8oxoG:C-labeled duplex in 20 mmol/L Tris–
HCl (pH 7.1), 1 mmol/L EDTA, 200 mmol/L NaCl, 1 mg/mL bovine serum albumin (BSA), 
and 5% glycerol. After 15 min at 37°C, the incision reaction was stopped by adding 4 μL of 
formamide dye and heating for 5 min at 95°C. The cleaved product was separated from the 
intact substrate in a 20% polyacrylamide gel containing 8 M urea in Tris-borate-EDTA buffer, 
pH 8.4. Fluorescence in the separated DNA bands was visualized using a LI-COR Odyssey 
CLx system. 
 
8oxoG ELISA 
Cell lysates were assessed for 8oxoG expression using a competitive ELISA assay (Abcam) 
as per the manufacturer’s instructions. Total DNA was purified from VSMC lysates by using 
the DNeasy Blood & Tissue Kit (Qiagen). DNA was digested using nuclease P1 following the 
manufacturer’s instructions. The pH was adjusted to 7.5-8.5 using 1M Tris and 1 unit 
alkaline phosphatase added per 100 μg DNA and incubated at 37°C for 30 minutes. 
Samples were boiled for 10 min and placed on ice until use. Absorbance was measured on 
a Synergy HT Plate Reader (Biotek) with standard curves generated from known 
concentrations of 8oxoG standards. 
 
Intracellular ROS measurement 
Intracellular ROS was measured by using the oxidant-sensitive fluorescent probe 5-(and-6)-
chloromethyl-2',7'-dichlorodihydrofluorescein diacetate acetyl ester (CM-H2DCFDA,10 mM; 
Molecular Probes). Cells were incubated continuously with CM-H2DCFDA during 
experimental conditions. Subsequently, cells were washed and lysed in 0.1% Triton X-100. 
Fluorescence was measured in the Biotek synergy HT plate reader with excitation of 488 nm 
and emission of 530 nm. 
 
Annexin V/PI flow cytometry 
Cell death was determined using an Apoptosis Detection kit according to the manufacturer’s 
instructions (BD BioSciences). Briefly, cells (1 × 105 cells/sample) were washed twice in cold 
PBS and suspended in binding buffer containing fluorescein isothiocyanate-conjugated 
annexin V (10 μg/ml) and PI (10 μg/ml). The cell suspension was incubated in the dark for 
15 min and fluorescence measured using an Accuri C6 flow cytometer (BD Biosciences). A 
total of 10,000 events were analyzed for each sample with Cell Quest software (BD 
Biosciences). 
 
Comet assay 
5 × 104 VSMCs were washed with PBS, resuspended in 150 µl 1% low melting point 
agarose (LMPA) and left to cool on Gel-bond films (Trevigen) at 4˚C for 10 min to set the 
agarose. Gel-bond films were incubated overnight in lysis buffer at 4˚C, washed briefly with 
water, and placed in alkaline electrophoresis buffer for 30 min prior to electrophoresis at 26V 
for 30 min at 4˚C. Gel-bond films were washed in neutralization buffer (100 mM Tris pH 7.6) 
and subsequently immersed in ice-cold ethanol for 10 min. Films were dried overnight, 
rehydrated in distilled H2O for 10 min and stained with 2µg/ml ethidium bromide (Sigma) 
solution in the dark at RT for 2 h. Multiple images per slide were analysed using a Zeiss 
microscope and comet tail length/moment measured using Comet Assay IV software 
(Perception Instruments). 
 
Immunofluorescence 
VSMCs for immunofluorescence and Proximity Ligation Assay (PLA) were cultured in 
chamber slides (ThermoFisher Scientific), fixed with 4 % paraformaldehyde for 15 min and 
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permeabilized for 5 min with 0.5% Triton X-100 in PBS prior to blocking with 3% BSA for 1 h. 
For immunofluorescence, cells were incubated with the following primary antibodies: rabbit 
anti-acetyl OGG1 (1:200, ab93670, Abcam) and rabbit anti-myc tag (1;1000, 2272S, Cell 
Signaling). Secondary antibodies were anti-rabbit Alexa Fluor 568, anti-mouse Alexa Fluor 
568 and anti-mouse Alexa Fluor 594 (1:1000, Invitrogen). Nuclei were visualized using DAPI. 
PLA was performed according to manufacturer’s instructions using the Duolink® In Situ Red 
Kit Mouse/Rabbit (Sigma) and the following primary antibodies: rabbit-anti OGG1 (1:200, 
PA1-16505, Thermofisher), mouse anti-p300 (1:100, NB100-616, Novus) and mouse anti-
SIRT1 (1:100, 8469S, Cell Signaling). Nuclei were visualized using DAPI. Slides were 
mounted with DAPI-containing medium (Sigma or Vectashield, Vector Labs) and visualized 
with a BX51 fluorescent microscope (Olympus). 
 
Immunoprecipitation 
VSMCs were harvested in RIPA lysis buffer (20 mM Tris-HCl pH7.5, 150 mM NaCl and 
Triton 0.5 %) supplemented with protease and phosphatase inhibitor cocktails (Sigma). After 
clarification by centrifugation, 800 μg of total protein cell lysate was incubated with 4 µg of 
rabbit anti-OGG1 antibody (PA1-16505, Thermofisher) overnight at 4 °C. Immuno-
complexes were precipitated with Pierce protein A/G magnetic beads for 4h at 4°C and 
detected by western blot with goat anti-OGG1 (PA5-18747, 1:500, Thermofisher), mouse 
anti-p300 (RW128, 1:500, Millipore), or mouse anti-SIRT1 (8469S, 1:1000, Cell Signaling) 
antibodies. Primary antibodies were detected using HRP-conjugated secondary antibodies 
and chemiluminescence (Amersham ECL or ECL prime reagents) detection. 
 
Western blotting 
Whole cell protein lysates were prepared using CelLytic reagent (Sigma). Immunoblotting of 
cell lysates was performed according to standard conditions. Immunoblots were labelled with 
the following primary antibodies: rabbit anti-acetyl histone 4 (1:1000, 06-866, Millipore), 
rabbit anti-acetyl OGG1 (1:1000, ab93670, Abcam), rabbit anti-myc tag (1;1000, 2272S, Cell 
Signalling, rabbit anti-NEIL1 (1:1000, ab128294, Abcam), mouse anti-NTH1 (1:500, 
ab70726, Abcam), rabbit anti-OGG1 (1:1000, ab124741, Abcam), mouse anti-p300 (1:500, 
RW128, Millipore), mouse anti-SIRT1 (1:1000, 8469S, Cell Signaling). Primary antibodies 
were detected using fluorescently labelled secondary antibodies: goat anti-rabbit IgG 
DyLight 680 and goat anti-mouse IgG Dylight 800 (Thermo Scientific). Detection and 
quantification of fluorescence intensity were performed using an Odyssey® CLx imaging 
system (LI-COR Biosciences, Lincoln) and Odyssey® 2.1 software. In some instances, 
HRP-conjugated secondary antibodies were used for chemiluminescence detection and 
protein levels quantified by densitometry and normalized against loading controls. 
 
ChIP-qPCR 
ChIP was performed using the ChIP-IT express kit (Active Motif), VSMCs were crosslinked 
for 10 min with formaldehyde (to a final concentration of 1 %). Chromatin was sheared using 
a Bioruptor UCD-200 ultrasound sonicator (Diagenode), resulting in DNA fragments of 500–
1000 bp in size. Chromatin was immunoprecipitated with 2 μg mouse anti-8oxoG antibody 
(MAB3560, Millipore) or negative control mouse IgG (PP64, Millipore). Immunoprecipitated 
DNA was then used as a template for quantitative PCR using primers specific for genomic 
loci. Oligonucleotide sequences used are listed in Supplementary Table S1. 
 
	
Primers Oligonucleotide Sequences
CASP1 (mouse)
Forward 5’- GCCCACCACTGAAAGAGTGA -3’
Reverse 5’- TCTTCACTTCCTGCCCACAG-3’
CCL2 (mouse)
Forward 5’- AGCTGTAGTTTTTGTCACCAAGC -3’
Reverse 5’- GTGCTGAAGACCTTAGGGCA -3’
GAPDH (human)
Forward 5’- GATGCCCCCATGTTCGTCAT-3’
Reverse 5’- TGCAGGAGGCATTGCTGATG-3’
GAPDH (mouse)
Forward 5’- GGGTCCCAGCTTAGGTTCATC-3’
Reverse 5’- CCCAATACGGCCAAATCCGT-3’
HPRT (mouse)
Forward 5’- ACAGGCCAGACTTTGTTGGA-3’
Reverse 5’- TGCAGATTCAACTTGCGCTC-3’
NLRP1 (mouse)
Forward 5’- TGGTTCAGGGATGCTGGAAA-3’
Reverse 5’- GCTGCTGGGCACTAGTATCTC-3’
NLRP3 (mouse)
Forward 5’- TCCTGGCTGTAACATTCGGAG-3’
Reverse 5’- TGCAAGATCCTGACAACATGC-3’
Il1b (mouse)
Forward 5’- GCCACCTTTTGACAGTGATGAG-3’
Reverse 5’- GACAGCCCAGGTCAAAGGTT-3’
IL6 (mouse)
Forward 5’- GACAAAGCCAGAGTCCTTCAGA-3’
Reverse 5’- TGTGACTCCAGCTTATCTCTTGG -3’
IL18 (mouse)
Forward 5’- TCTTGGCCCAGGAACAATGG-3’
Reverse 5’- ACAGTGAAGTCGGCCAAAGT-3’
OGG1 human
Forward 5’- GACTACAGCTGGCACCCTAC-3’
Reverse 5’- CACTGAACAGCACCGCTTG-3’
OGG1 (genotyping mouse)
Forward 5’- GAGACACATCTTGCAGGGAGC-3’
Reverse 5’- ACTCAGGACCTTCAGAAGAGCA-3’
Neo 5’- GATGGATACTTTCTCGCAGG-3’
OGG1 (mouse)
Forward 5’- CCACCCTAGAGGAGCTGGAA-3’
Reverse 5’- CAGCAGTCTCACACCTTGGA-3’
P300 (human)
Forward 5’- GCAGTGTGCCAAACCAGATG-3’
Reverse 5’- CATAGCCCATAGGCGGGTTG-3’
SIRT1 (human)
Forward 5’- GGGCTGCGGTTCCTACTG-3’
Reverse 5’- CAGACACCTATCCGTGGCCT-3’
Telomere ChIP Forward 5’- GGTTTTTGAGGGTGAGGGTGAGGGTGAGGGTGAGGGT-3’
Reverse 5’- TCCCGACTATCCCTATCCCTATCCCTATCCCTATCCCTA-3’
TNFα (mouse)
Forward 5’- GATCGGTCCCCAAAGGGATG -3’
Reverse 5’- CCACTTGGTGGTTTGTGAGTG-3’
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Supplemental Figure I
Western blot analysis for the nuclear marker histone H3, cytoplasmic marker GAPDH, and
mitochondrial marker cytochrome c in nuclear or cytoplasmic subfractions of human plaque or
normal aortic VSMCs (n=3).
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Supplemental Figure II
(a) Western blot analysis for OGG1, NEIL1 and NTH1 in Control (Ctrl), OGG1Exon1KO and
OGG1Exon7KO rat VSMCs (n=4). (b) Immunofluorescence analysis of transgene expression (myc
tag; left panel) or Ac-OGG1 (right panel) in VSMCs expressing the empty vector (Ctrl), OGG1 or
OGG1K-R (n=3). (c) Quantification of intracellular ROS levels in Ctrl, OGG1 or OGG1K-R VSMCs
measured by DCFDA fluorescence (n=3).
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Supplemental Figure III
(a) qPCR analysis of p300 expression in cultured human plaque or normal aortic VSMCs (n=4). (b)
Immunohistochemistry analysis and quantification of p300 (brown) and αSMA (blue) staining in tissue 
sections of human plaques and normal aorta (n=10). High power magnification views of areas outlined 
on left are shown and quantification. Scale markers, 25µm. (c) Quantification of relative Ac-OGG1 and 
p300 protein expression after t-BHP treatment and 0-24h recovery in control VSMCs (n=3). (d) Negative 
control PLA analysis using rabbit anti-OGG1 and mouse anti-p300 antibodies alone or with mouse IgG
and rabbit IgG respectively (n=3). All graphical data are mean ± SEM, *P< 0.05, **P< 0.01, Student’s t-
test.
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Supplemental Figure IV
(a) Representative BER assay in SM22α-OGG1 and SM22α-OGG1K-R mouse VSMCs (left) 
±CTPB (10μM) after 1h t-BHP treatment and 0- 6h recovery (n=3). (b) BER assay and 
quantification in control VSMCs either untreated (UT, -), after 1h t-BHP (0) or 6h recovery ± C646 
(10μM) (n=3). (c) Western blot showing levels of OGG1 after CHX treatment in Ctrl, OGG1 or 
OGG1K-R VSMCs (n=4). (d) Quantification of Western blot in Figure 3g showing levels of OGG1 
after CHX treatment in OGG1 or OGG1K-R VSMCs ±CTPB (n=3). (e) Quantification of Western blot 
in Figure 3h of OGG1 levels after CHX treatment in control VSMCs ± p300 inhibitor C646 and 
MG132 (10μM) (n=3). All graphical data are mean ± SEM, *P< 0.05, Student’s t-test or one-way 
ANOVA (Bonferroni post hoc).
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Supplemental Figure V
(a) PLA analysis using mouse anti-SIRT1 antibody alone or with rabbit IgG as negative 
controls (n=3). (b) Representative image of BER assay gel showing Ctrl, SIRT1 and SIRT1H-Y
cells after 1h t-BHP treatment and 0-24h recovery (n=3). (c) Quantification of intracellular
ROS levels in Ctrl, SIRT1 and SIRT1H-Y VSMCs after 1h t-BHP treatment and 0-24h recovery
measured by DCFDA fluorescence (n=3).
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Supplemental Figure VI
(a) qPCR analysis of mouse (mOGG1; left panel) and human (hOGG1; right panel) OGG1 in 
liver, small intestine, heart and aorta tissue from control, SM22α-OGG1,SM22α-OGG1K-R and 
OGG1-/- mice (n=4). (b) qPCR analysis of SM22α-OGG1 in aorta tissue, peripheral blood, 
bone marrow cells and spleen from control and SM22α-OGG1 mice (n=3). (c) Representative 
BER assay in Control, SM22α-OGG1,SM22α-OGG1K-R and OGG1-/- mouse VSMCs after 1h t-
BHP treatment and 0-24h recovery (n=3). All graphical data are mean ± SEM, ***P< 0.001, 
one-way ANOVA (Bonferroni post hoc).
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aSupplemental Figure VII
(a) Body weight gain, (b) serum lipids and (c) blood pressure and heart rates in Control ApoE-/- (n=12), 
OGG1-/- ApoE-/- (n=14), SM22α-OGG1 ApoE-/- (n=12) and SM22α-OGG1K-R ApoE-/- (n=13) mice pre- and 
post- fat feeding from 8-22 weeks (14w HFD).  
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Supplemental Figure VIII
(a) Morphometry of plaques in experimental mice. Quantification of aortic root plaque, core and cap area 
ratios in control ApoE–/– (n=12), OGG1-/-/ApoE-/- (n=14), SM22α-OGG1/ApoE–/– (n=5 as caps/cores not 
discernible in very small lesions) and SM22α-OGG1K-R/ApoE–/–(n=13) mice at 22 weeks after fat feeding 
from 8 to 22 weeks (n= 11-14). (b) Plaque area of aortic roots in male and female study mice (µm2). (c)
8oxoG and TUNEL immunohistochemistry analysis of Control ApoE-/- (n=12), OGG1-/- ApoE-/- (n=14), 
SM22α-OGG1 ApoE-/- (n=12) and SM22α-OGG1K-R ApoE-/- (n=13) mouse aortic roots at 22 weeks after fat 
feeding. Negative controls and % 8oxoG-positive aortic area and % TUNEL-positive aortic cells in aortic 
roots are shown below. All graphical data are mean ± SEM, *P< 0.05, **P<0.01, one-way ANOVA 
(Bonferroni post hoc).
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Supplemental Figure IX
Representative images of senescence-associated b-galactosidase activity of VSMCs 
cultured from Control, OGG1-/-, SM22α-OGG1, SM22α-OGG1K-R mice (n=3).
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Supplemental Figure X
(a) Serum cytokines from a subset of Control, OGG1-/-, SM22α-OGG1, SM22α-OGG1K-R mice at 22 
weeks after fat feeding from 8-22 weeks (n=6). (b) Levels of CCL2/MCP1, IL1β, IL2, IL6, IL10 and 
TNFα in conditioned media from experimental mouse VSMC cultures stimulated with t-BHP 
measured by multiplex ELISA (n=3), Student’s t-test. All graphical data are mean ± SEM, *P < 0.05, 
**P < 0.01, one-way ANOVA (Bonferroni post hoc).
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